School of Medicine
Showing 901-1,000 of 12,907 Results
-
David Bergman
Associate Professor of Pediatrics (General Pediatrics) at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsMy research has involved the use of new technologies to create different types of patient-doctor transactions. I am also interested in how these new transactions impact clinical care processes. Current work includes the evaluation of a patient portal for children with cystic fibrosis, the use of telemedicine to bring asthma experts into the schools and the attitudes of teens and parents about the use of a secure patient portal for teens.
-
Dominique Bergmann
Shirley R. and Leonard W. Ely, Jr. Professor of the School of Humanities and Sciences
Current Research and Scholarly InterestsWe use genetic, genomic and cell biological approaches to study cell fate acquisition, focusing on cases where cell fate is correlated with asymmetric cell division.
-
Brandon Bergsneider
MD Student with Scholarly Concentration in Informatics & Data-Driven Medicine / Immunology, expected graduation Spring 2026
BioBrandon Hwa-Lin Bergsneider, from Los Angeles, CA, is pursuing an MD at Stanford School of Medicine. Brandon earned a bachelor of science in human biology from Stanford, and a MSc in bioinformatics and theoretical systems biology from Imperial College London. Brandon aspires to use data science-based technologies to advance health equity through early diagnosis, democratizing health information, and improving treatment efficacy. At Stanford and Imperial, he researched the molecular bases of neurodegeneration, the genetic susceptibility of neuroblastoma patients to SARS-CoV-2, computational protein structure prediction, and using machine learning to identify chemotherapy-resistant cancer cells. Brandon has also worked at the National Institutes of Health, where he used computational network analysis to identify clinical and demographic determinants of brain tumor patient symptom burden. Brandon has multiple first-author publications and, outside of academics, enjoys volunteering as a surf-therapy instructor for military veterans. He is a Knight-Hennessy Scholar, a Fulbright Scholar, and an NIH Cancer Research Training Award Fellow.
-
Michele Berk, Ph.D.
Associate Professor of Psychiatry and Behavior Sciences (Child and Adolescent Psychiatry and Child Development)
Current Research and Scholarly InterestsThe focus of my research is on adolescent suicidal and self-harm behavior. I am currently one of four Principal Investigators of a multisite NIMH-sponsored RCT of DBT for adolescents at high risk for suicide (NCT01528020: Collaborative Adolescent Research on Emotions and Suicide [CARES], PI: Linehan, McCauley, Berk, & Asarnow) aimed at evaluating the efficacy of DBT with adolescents compared to a combined individual and group supportive therapy control condition (IGST).
-
Roberto J. Bernardo MD, MS, ATSF
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
Current Research and Scholarly InterestsExercise hemodynamics and cardiopulmonary exercise testing
-
Daniel Bernstein
Alfred Woodley Salter and Mabel G. Salter Endowed Professor of Pediatrics
Current Research and Scholarly Interests1. Using iPSC-derived cardiomyocytes to understand hypertrophic cardiomyopathy and heart failure associated with congenital heart disease.
2. Role of alterations in mitochondrial dycamics and function in normal physiology and disease.
3. Differences between R and L ventricular responses to stress,
4. Immune biomarkers of risk after pediatric VAD implantation.
5. Biomarkers for post-transplant lymphoproliferative disorder. -
Jon Bernstein
Professor of Pediatrics (Genetics) and, by courtesy, of Genetics
Current Research and Scholarly InterestsMy research is focused on the diagnosis, discovery and delineation of rare genetic conditions with a focus on neurodevelopmental disorders. This work includes the application of novel computational methods and multi-omics profiling (whole genome sequencing, long-read DNA sequencing, RNA sequencing, methylomics, metabolomics). I additionally participate in an interdisciplinary project to develop induced pluripotent stem cell and assembloid models of genetic neurodevelopmental disorders.
-
Wendy J. Bernstein
Adjunct Clinical Instructor, Psychiatry and Behavioral Sciences
BioSenior Community Psychiatrist, Wellness Equity Alliance, Medical Director, Project ECHO and Telemedicine for Severe Mental Illness Track to support the Mental Health of SGBV survivors in Democratic Republic of Congo project. Past Associate Medical Director at Casa del Sol, specialty mental health clinic of La Clinica de la Raza in Oakland California from 2013 to July 2021. Previously at Kaiser Permanente, Northern California, from 2000 to 2013, and Contra Costa County Older Adults Clinics from 1995-2000. Graduate of McGill University Faculty of Medicine, Montreal, Canada, and Boston University Psychiatry Residency. Interests include global health, community mental health, Latinx and underserved populations, women's health, and elder care.
-
William Berquist, MD
Professor of Pediatrics (Gastroenterology), Emeritus
Current Research and Scholarly InterestsPediatric Gastroenterology, hepatology and nutrition.
-
Gerald Berry
Richard Kempson, M.D., Professor of Surgical Pathology
Current Research and Scholarly InterestsCardiopulmonary and pulmonary transplant medicine; diagnostic surgical pathology
-
Mark Francis Berry, MD
Mylavarapu Rogers Professor of Cardiothoracic Surgery
BioDr. Berry joined the Division of Thoracic Surgery at Stanford in August 2014. He came to Stanford from Duke University, where he had most recently served as Associate Professor. He received his medical degree at the University of Pennsylvania School of Medicine after receiving bachelors and masters degrees in Electrical Engineering at the University of Pennsylvania. He completed his residency in Cardiothoracic Surgery at Duke University Medical Center after performing a residency in General Surgery at the Hospital of the University of Pennsylvania. His Cardiothoracic Surgical training included a year dedicated to Minimally Invasive General Thoracic Surgery, a period that also included an American Association for Thoracic Surgery sponsored Traveling Fellowship at the University of Pittsburgh.
Dr. Berry practices all aspects of thoracic surgery, including procedures for benign and malignant conditions of the lung, esophagus, and mediastinum. He has a particular interest in minimally invasive techniques, and has extensive experience in treating thoracic surgical conditions using video-assisted thoracoscopic surgical (VATS), laparoscopic, robotic, endoscopic, and bronchoscopic approaches. He serves as the co-Director of the Stanford Minimally Invasive Thoracic Surgery Center (SMITS), and has both directed and taught in several minimally invasive thoracic surgery courses.
Dr. Berry also has a Masters of Health Sciences in Clinical Research from Duke University. His clinical research activities mirror his clinical interests and activities in optimizing short-term and long-term outcomes of patients with thoracic surgical conditions. He has more than 150 peer-reviewed publications, most of which are related to both the use of minimally invasive thoracic surgical techniques as well as evaluating outcomes after treatment of thoracic malignancies. His clinical practice and his research both focus on choosing the most appropriate treatment and approach for patients based on the individual characteristics of the patient and their disease process. -
Edward Bertaccini
Professor of Anesthesiology, Perioperative and Pain Medicine (MSD), Emeritus
Current Research and Scholarly Interestsmolecular modeling of anesthetic-protein interactions, molecular modeling of the ligand-gated ion channels
-
Alice Bertaina MD, PhD
Lorry I. Lokey Professor
Current Research and Scholarly InterestsDr. Bertaina is a highly experienced clinician and will play a key role in supporting Section Chief Dr. Rajni Agarwal and Clinical Staff in the Stem Cell Transplant Unit at Lucile Packard Children’s Hospital. She will also continue her research on immune recovery and miRNA, understanding the mechanisms underlying immune reconstitution, Graft-versus-Host Disease (GvHD), and leukemia relapse after allogeneic HSCT in pediatric patients affected by hematological malignant and non-malignant disorders.
-
Carolyn Bertozzi
Baker Family Director of Sarafan ChEM-H, Anne T. and Robert M. Bass Professor in the School of Humanities and Sciences and Professor, by courtesy, of Chemical and Systems Biology
BioCarolyn Bertozzi is the Baker Family Director of Sarafan ChEM-H, Anne T. and Robert M. Bass Professor in the School of Humanities and Sciences and Professor, by courtesy, of Chemical and Systems Biology and of Radiology at Stanford University, and an Investigator of the Howard Hughes Medical Institute. She completed her undergraduate degree in Chemistry from Harvard University in 1988 and her Ph.D. in Chemistry from UC Berkeley in 1993. After completing postdoctoral work at UCSF in the field of cellular immunology, she joined the UC Berkeley faculty in 1996. In June 2015, she joined the faculty at Stanford University and became the co-director and Institute Scholar at Sarafan ChEM-H.
Prof. Bertozzi's research focuses on fundamental studies of disease-associated glycobiology and the development of new therapeutic modalities that target these pathways. Her inventions include bioorthogonal chemistries for in vivo imaging and bioconjugation, work for which she received the 2022 Nobel Prize in Chemistry. As well, her lab has developed next generation antibody-drug conjugates, lysosome-targeting chimeras (LYTACs), antibody-enzyme conjugates and antibody-lectin chimeras. Several of these new therapeutic modalities have been translated into clinical candidates for treatment of cancer and autoimmune diseases.
In addition to the Nobel Prize, Prof. Bertozzi has been recognized with many honors and awards for both her research and teaching accomplishments. For example, she is an elected member of the National Academy of Sciences, the National Academy of Medicine, the National Inventors Academy and the National Academy of Engineering, the American Academy of Arts and Sciences, the German Academy of Sciences Leopoldina, and she is a Foreign Fellow of the Royal Society. In addition, Prof. Bertozzi received the Priestley Medal of the American Chemical Society, the Welch Award, the Wolf Prize in Chemistry, the Heineken Prize, Lemelson-MIT award for inventors, and a MacArthur "Genius Award". -
Allison Betof, MD, PhD
Associate Professor of Medicine (Oncology)
BioDr. Allison Betof is an Associate Professor of Medicine (Oncology), Director of the Melanoma Program, Director of Solid Tumor Cellular Therapy, and Mark & Mary Stevens Endowed Scholar in Melanoma at Stanford University School of Medicine. Dr. Betof completed her MD and PhD at Duke University, Internal Medicine residency at Massachusetts General Hospital (Harvard University) and Medical Oncology Fellowship at Memorial Sloan Kettering Cancer Center. Dr. Betof’s laboratory focuses on understanding resistance to immune checkpoint blockade and cellular therapies for melanoma and other solid tumors. She is the Principal Investigator of clinical trials exploring novel treatments for immunotherapy-refractory melanoma and is internationally recognized for her expertise in brain/CNS metastasis and the use of novel cellular therapies. Dr. Betof has been a pioneer in the use of commercial tumor infiltrating lymphocyte (TIL) therapy for the treatment of melanoma and other solid tumors. She has received funding and awards for her clinical and translational investigative work from multiple high-profile organizations, including the American Society of Clinical Oncology (ASCO), National Institutes of Health (NIH), Melanoma Research Alliance, and Melanoma Research Foundation.
-
Samuel Beuret
Postdoctoral Scholar, Radiology
BioI received the B.Sc., M.Sc., and Ph.D. degrees in Electrical Engineering from the École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland, in 2016, 2019, and 2024, respectively. After working as an Ultrasound Engineer at E-Scopics, Aix-en-Provence, France, I joined the Ultrasound Imaging and Instrumentation Lab of the Department of Radiology as a Postdoctoral Scholar in 2025. My research interests include signal processing, inverse problems, and probabilistic modeling applied to pulse-echo ultrasound imaging. My current work focuses on improving pulse-echo speed-of-sound imaging and distributed aberration correction.
-
Jill Beyer, OD
Clinical Associate Professor, Ophthalmology
BioJill Beyer, OD, is a Clinical Assistant Professor at Stanford University School of Medicine.
Dr. Beyer graduated from Southern California College of Optometry, earning her Doctor of Optometry degree with distinction. She completed her residency at New England College of Optometry in Boston, Massachusetts, and earned a Bachelor of Science degree in Biology from Oregon State University.
Jill’s residency education included time spent at the Boston Foundation for Sight, Massachusetts Eye and Ear Infirmary, Cornea Consultants & Boston Laser Center, and Harvard Vanguard Medical Associates.
After residency training, Jill continued on as a clinical preceptor at the New England College of Optometry while working in private practice in Boston. She then transitioned to full time academic work at the Massachusetts Eye and Ear Infirmary becoming the Director of the Contact Lens Department and an Instructor in Ophthalmology at Harvard Medical School. -
Gala Beykin, MD
Clinical Instructor, Ophthalmology
BioDr. Beykin is an ophthalmologist and glaucoma specialist at the Byers Eye Institute at Stanford Health Care. She is also a clinical instructor in the Department of Ophthalmology at Stanford University School of Medicine.
Dr. Beykin completed clinical and surgical training in glaucoma at the Byers Eye Institute. She specializes in caring for patients with all types of ophthalmic conditions, including glaucoma and cataract.
She has expertise in clinical trial design and implementation, and studies novel biomarkers and candidate therapeutics for vision protection and restoration in glaucoma. Her research efforts include numerous clinical trials investigating new therapies for eye conditions. Dr. Beykin has participated in multiple studies evaluating drugs targeting retinal disease such as AMD and diabetes-related vision loss, as well as ongoing clinical trials assessing new treatment strategies for neuroprotection, neuroregeneration and neuroenhancement in glaucoma. These include implants that could potentially stop or slow the progression of and help improve vision.
Dr. Beykin has published her work in numerous peer-reviewed journals, including the British Journal of Ophthalmology and Investigative Ophthalmology & Visual Science. She has presented her work at national and international meetings, including those for the International Symposium on Retinal Degeneration and the Association for Research in Vision and Ophthalmology.
She is a member of the Israeli Ophthalmology Society, the Israeli Society for Eye and Vision Research, and the Association for Research in Vision and Ophthalmology. -
Vivek Bhalla, MD
Associate Professor of Medicine (Nephrology)
Current Research and Scholarly InterestsDr. Bhalla's two primary research interests are in the role of the kidney in diabetes and hypertension. We use molecular, biochemical, and transgenic approaches to study: (1) mechanisms diabetic kidney disease disease including the role of the endothelium to regulate inflammation and kidney injury; and (2) regulation of tubular transport of glucose, sodium, and potassium. These latter studies have treatment implications in diabetes, kidney disease, and hypertension.
-
Rashmi Parekh Bhandari
Clinical Professor, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsClinical interventions, treatments, and outcomes in pediatric pain management
-
Sushma Bharadwaj, MD
Clinical Assistant Professor, Medicine - Blood & Marrow Transplantation
BioDr. Bharadwaj is fellowship-trained in blood and marrow transplantation, cellular therapy, hematology, and oncology. She is an instructor in the Stanford School of Medicine Department of Medicine, Division of Blood & Marrow Transplantation and Cellular Therapy.
Dr. Bharadwaj focuses her expertise on diagnosing and treating cancer in blood and bone marrow. For each patient, she develops a personalized, comprehensive, and compassionate care plan. In her diverse experience as a physician and scientist, she has served as an internal medicine doctor, hospitalist, hematologist, oncologist, and blood and marrow transplantation specialist. Dr. Bharadwaj has a degree in clinical research and is currently conducting clinical trials in transplant and cellular therapy.
She has participated in research studies of advances in therapy for chronic lymphocytic leukemia, melanoma, and breast cancer. She has co-authored articles published in Leukemia and Lymphoma and elsewhere. Topics include advances in cell transplantation. She also co-wrote the chapter on genome-driven personalized cancer therapy in the book Precision Medicine in Oncology.
Dr. Bharadwaj has made presentations at meetings of the American Society of Hematology, American Society of Clinical Oncology, and other associations.
Subjects include racial, demographic, and socioeconomic disparities in the treatment of patients with acute myeloid leukemia.
Dr. Bharadwaj is a member of the American Society for Transplantation and Cellular Therapy, American Society of Hematology, and American Society of Clinical Oncology. -
Mahendra T. Bhati
Clinical Professor, Psychiatry and Behavioral Sciences
Clinical Professor, NeurosurgeryBioDr. Bhati is an interventional psychiatrist with expertise in psychiatric diagnosis, psychopharmacology, and neuromodulation. He completed postdoctoral research studying language abnormalities and transcranial magnetic stimulation (TMS) evoked potentials in schizophrenia. He was a principal investigator for the DSM-5 academic field trials, and his research experiences included roles in the first controlled clinical trials of TMS and deep brain stimulation (DBS) for treatment of depression. He was the founding Chief of Interventional Psychiatry at Stanford where he performs consultations and provides pharmacological and neuromodulatory treatments. His current research interests include studying magnetic resonance imaging and augmented reality to target TMS, vagus nerve stimulation (VNS) for treatment-resistant depression, DBS for obsessive-compulsive disorder (OCD) and depression, responsive neurostimulation (RNS) for treatment of impulse and fear-related disorders, and focused ultrasound (FUS) for treatment-resistant OCD and depression. Dr. Bhati seeks to train more providers in mental healthcare and founded a clinical fellowship in Interventional Psychiatry at Stanford.
-
Richa Bhatia, MD
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Bhatia is a Distinguished Fellow of the American Psychiatric Association and Clinical Associate Professor in the Department of Psychiatry at Stanford University School of Medicine. She is a dual Board-certified child, adolescent and adult psychiatrist, specializing in treating anxiety disorders. Her work has been cited in Time magazine and Scientific American, and her professional opinions have been quoted in media such as CNBC, The Guardian, U.S. News and World Report, The Wall Street Journal, CBS News Bay Area, WUCF-TV (PBS), and others. Dr. Bhatia served as President-Elect of Northern California Psychiatric Society. She is an avid advocate of improving mental health awareness and reducing the stigma surrounding psychiatric conditions and treatments. For her work in this arena, she was awarded the 2021 Jerilyn Ross Clinician Advocate Award by the Anxiety and Depression Association of America and the Marian Butterfield award in 2018. Her other roles include serving as Section Editor for Current Opinion in Psychiatry, a Wolters Kluwer journal, for the last 7 years. She also served as Associate Editor of Current Psychiatry for 6 years. She is often invited to give talks at national, regional and local conferences and organizations.
She values the academic as well as the humanistic aspects of psychiatry. During her psychiatry residency training from 2007 to 2010, she scored between 94th and 98th percentile among US psychiatry resident physicians. She takes a whole-person approach, utilizing active, empathic listening and aimed at understanding the biological, psychological, social, and other factors affecting an individual’s mental health. She integrates medication management (where needed) with psychotherapy. Her psychotherapy approach is informed by various evidence-based psychotherapies such as psychodynamic therapy, acceptance and commitment therapy, and mindfulness-based, compassion-focused interventions. Dr. Bhatia’s other professional interests include ruling out medical conditions mimicking psychiatric disorders, diagnostic errors, mindfulness, bullying prevention, and compassion and empathy cultivation. -
Ritwik Bhatia, MD
Clinical Assistant Professor, Adult Neurology
BioDr. Bhatia is a board-certified, fellowship-trained neurologist with Stanford Health Care and a clinical assistant professor in the Department of Neurology and Neurological Sciences, Division of Neurocritical Care at Stanford University School of Medicine.
Dr. Bhatia joined Stanford in 2024 after completing Neurocritical Care fellowship at the University of California, San Francisco. He provides critical care to patients following acute neurological injuries, such as stroke, traumatic brain injury, intracranial hemorrhage, and other disorders affecting the brain, spinal cord, and nervous system. He strives to provide excellent patient care in multidisciplinary teams. He enjoys teaching and is the physician lead for simulation for Advanced Practice Providers in Neurocritical Care. He currently serves as the Unit Based Medical Director for the Neurosciences ICU at Stanford Hospital, leading the unit's initiatives in quality and patient safety.
Dr. Bhatia’s research interests include longitudinal outcomes for patients with moderate-severe acute acquired brain injury requiring intensive care unit admission. He is developing a neurointensive care recovery clinic at Stanford Healthcare to follow these patients through transitions of care and support neurorecovery.
Dr. Bhatia has published in several peer-reviewed journals, including Neurology, Journal of Neurosurgery, and Stroke. He has presented at national meetings for the American Academy of Neurology, Society of Vascular and Interventional Neurology, and American Epilepsy Society. He has served as a guideline ambassador for the American Heart Association and is a member of the Neurorecovery Clinic Section of the Neurocritical Care Society. In his spare time, he enjoys spending time with family and friends. -
Ami Bhatt
Professor of Medicine (Hematology) and of Genetics
Current Research and Scholarly InterestsThe Bhatt lab is exploring how the microbiota is intertwined with states of health and disease. We apply the most modern genetic tools in an effort to deconvolute the mechanism of human diseases.
-
Apurva Bhatt
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioApurva Bhatt, M.D., is a child, adolescent and adult psychiatrist and Clinical Assistant Professor at Stanford University School of Medicine. Her role spans the General Adult Psychiatry Division, Child Psychiatry Division, and Center for Youth Mental Health and Wellbeing.
Dr. Bhatt specializes in early psychosis evaluation and treatment. She is the Director of the Child INSPIRE clinic and currently provides clinical care in both the Stanford Children’s Hospital Child INSPIRE early psychosis clinic and the Stanford Health Care INSPIRE clinic and INSPIRE360 Coordinated Specialty Care/Wraparound program. She contributes to early psychosis program development in California (through EPI-CAL as the Psychiatric Provider Team Lead) and nationally (through PEPPNET). She is also co-chair of the American Academy of Child and Adolescent Psychiatry Adolescent Psychiatry Committee and Early Psychosis work group.
Dr. Bhatt is also a school psychiatrist, providing school clinical consultations for the Redwood City School District through the Stanford Redwood City Sequoia School Mental Health Collaborative. She also provides clinical consultations to schools in the Los Altos School district, and supervises child and adolescent psychiatry fellows providing consultation to Los Altos, Redwood City, and Mountain View schools.
Dr. Bhatt’s research interests include Asian American and South Asian youth mental health and prevention of youth suicide. She enjoys teaching and mentoring students and trainees, and currently is a mentor through the American Academy of Child and Adolescent Psychiatry. -
Hilarey Ransom Bhatt
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Bhatt is an expert clinician, educator, and health system leader in the specialty of internal medicine. She earned her MD from University of California San Francisco School of Medicine and completed her training at UCSF’s Internal Medicine residency program. Dr. Bhatt is certified by the American Board of Internal Medicine. Dr. Bhatt cares for people ages 18 and up. She practices at Stanford Express Care in Palo Alto and San Jose, where she serves as the Medical Director of the clinic. She has a particular interest in the care of medically complex patients and in teaching and practicing evidence-based medicine. She believes that the patient-clinician relationship is the foundation of good care and strives to develop respectful and collaborative relationships with all her patients.
-
Jayanta Bhattacharya
Professor of Health Policy, Emeritus
Current Research and Scholarly InterestsMy research focuses on the constraints that vulnerable populations face in making decisions that affect their health status, as well as the effects of government policies and programs designed to benefit vulnerable populations.
-
Achintya K. Bhowmik, PhD
Adjunct Professor, OHNS/Otology & Neurotology Division
BioDr. Achin Bhowmik serves on the faculty of Stanford University as an adjunct professor at the Stanford School of Medicine, where he advises research and lectures in the areas of sensory augmentation, computational perception, cognitive neuroscience, and intelligent systems. He is also an affiliate faculty member of the Stanford Institute for Human-Centered Artificial Intelligence, Wu Tsai Neurosciences Institute and Human Performance Alliance, and a mentor for the Stanford Institutes of Medicine Summer Research Program.
Dr. Bhowmik is the chief technology officer and executive vice president of engineering at Starkey Hearing Technologies, a privately-held medical devices company with over 5,000 employees and operations in over 100 countries worldwide. In this role, he is responsible for the company’s technology strategy, research and development, engineering and program management departments, and leading the drive to transform hearing aids into multifunction wearable health and communication devices with advanced sensors and artificial intelligence.
Previously, Dr. Bhowmik was the vice president and general manager of the Perceptual Computing Group at Intel Corporation, where he was responsible for the R&D, engineering, operations, and businesses in the areas of 3D sensing and interactive computing, computer vision and artificial intelligence, autonomous robots and drones, and immersive virtual and merged reality devices.
Dr. Bhowmik is a member of the Forbes Technology Council, board of trustees for the National Captioning Institute, board of directors for Mojo Vision and OpenCV, board of advisors for the Fung Institute for Engineering Leadership at the University of California, Berkeley, and industry advisory board for the Institute for Engineering in Medicine and Biomedical Engineering at the University of Minnesota. He is also on the board of advisors for several technology startup companies.
He has also held adjunct and guest professor positions at the University of California, Berkeley, Liquid Crystal Institute of the Kent State University, Kyung Hee University, Seoul, and the Indian Institute of Technology, Gandhinagar. He received his Bachelor of Technology from the Indian Institute of Technology, Kanpur, PhD from Auburn University, and attended the Executive Program at Stanford University. He has authored over 200 publications, including two books and over 80 granted patents.
His awards and honors include Fellow of the Institute of Electrical and Electronics Engineers (IEEE), President and Fellow of the Society for Information Display (SID), Fellow of the Asia-Pacific Artificial Intelligence Association (AAIA), Artificial Intelligence Excellence award by the Business Intelligence Group, Gold Globee award for “Most Innovative Person of the Year in Healthcare”, Top 25 Healthcare Technology CTOs by the Healthcare Technology Report, Notable Leaders in Healthcare by Twin Cities Business, Healthcare Heroes award by the Business Journals, Industrial Distinguished Leader award from the Asia-Pacific Signal and Information Processing Association, TIME’s Best Inventions, and the Red Dot Design award.
Dr. Bhowmik and his work have been covered in numerous press articles, including TIME, Fortune, Wired, USA Today, US News & World Reports, Wall Street Journal, CBS News, BBC, Forbes, Bloomberg Businessweek, Scientific American, Popular Mechanics, MIT Technology Review, EE Times, The Verge, etc. -
Nidhi Bhutani
Associate Professor of Orthopaedic Surgery
Current Research and Scholarly InterestsThe long-term goal of our research is to understand the fundamental mechanisms that govern and reprogram cellular fate during development, regeneration and disease.
-
Vinod (Vinny) K. Bhutani
Professor of Pediatrics (Neonatology) at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsNeonatology; newborn jaundice, bilirubin biology and kernicterus prevention; pulmonary physiology, pulmonary functions and neonatal ventilation. To promote newborn screening for G6PD deficiency in USA.
-
Y. Katherine Bianco
Clinical Professor, Obstetrics & Gynecology - Maternal Fetal Medicine
BioMy clinical interest in pregnancies complicated with birth defects has led my underlying research interests in genomic abnormalities in the human trophoblast carrying to faulty placentation. The latter began with initial work during K12 and KO8 funding. I took a great interest in the human placenta as it carries potential advantages over other tissues sources: first, this highly metabolically active organ is the potential source of many transcripts. Second, the placenta forms at a very early stage of embryonic development, potentially allowing detection of primary alterations as compared to secondary changes that may mask the underlying causal phenomena. Finally, studying early placentation may provide targets for development of novel molecular approaches, such as up-regulate or down-regulate genes, the protein products of which could potentially serve as molecular surrogates for diagnosis and treatment of pregnancy complication such as miscarriages, pre-eclampsia, pregnancy induced hypertension and intrauterine growth retardation. This work has led to the first Trisomy 21, Trisomy 18, trisomy 13 cell lines established from human placentas making it possible to apply gene editing in the early stages of human trophoblast development.
As my primary clinical responsibility involves treating patients needing medical care and support through their high risk pregnancies, I am interested in factors that may impact outcomes, such as prenatal screening and diagnosis, maternal heart conditions, labor and delivery management, and safety approaches for the second stage of labor. In investigating length of labor and approaches to shorten the second stage, I have found methods of improving perinatal outcomes in diverse maternal populations.
With regards to my interest in fetal medicine, I have worked in collaboration with other specialists such as radiologists and pediatric cardiologists utilizing imagining studies to assess and determine successful perinatal care and fetal survival. -
Deeksha Suresh Bidare
Affiliate, Department Funds
Resident in SurgeryBioGeneral Surgery PGY-1
Stanford Medicine - Department of Surgery
M.D. | Baylor College of Medicine, 2023
B.S. in Biochemistry and Cell Biology | Rice University, 2019 -
Nasrin Biglari
Academic Technology Specialist, School of Medicine - Post Grad Med Education (CME)
Current Role at StanfordStanford Continuing Medical Education Website Coordinator/Developer
-
Vasiliki (Vicky) Bikia
Postdoctoral Scholar, Biomedical Data Sciences
BioDr. Vasiliki Bikia is a Postdoctoral Researcher at Stanford University, jointly affiliated with the Institute for Human-Centered Artificial Intelligence (HAI) and the Department of Biomedical Data Science, where she works under the mentorship of Prof. Roxana Daneshjou. She holds an Advanced Diploma in Electrical and Computer Engineering from the Aristotle University of Thessaloniki (AUTH), Greece (2017), and a Ph.D. in Biomedical Engineering from the Swiss Federal Institute of Technology of Lausanne (EPFL), Switzerland (2021). Her doctoral work focused on addressing the clinical need for non-invasive cardiovascular monitoring by combining machine learning with physics-based numerical modeling.
Dr. Bikia's research centers on the development of large multimodal models to improve patient outcome prediction. She is also passionate about building patient-facing chatbots that help individuals better understand complex medical information, ultimately aiming to enhance communication and empower patients in their care journey. Moreover, she has contributed to the Stanford Spezi framework, designing and prototyping the Spezi Data Pipeline tool for enhanced digital health data accessibility and analysis workflows. -
Mary Sheridan Bilbao, MPAS, PA-C
Physician Asst-Rsch, Cardiothoracic Surgery
BioMary Sheridan Bilbao, MPAS, PA-C, FAPACVS, is an accomplished advanced practice provider specializing in Cardiothoracic Surgery. She earned both her Undergraduate degree and Masters of Physician Assistant Studies at Marywood University. With extensive experience in cardiothoracic surgery, Mary became an integral part of our team in 2014.
Her expertise spans both in-patient and outpatient care, where she actively participates in surgical procedures and contributes to various studies and laboratory research. Mary's proficiency extends to open and endoscopic vein harvesting, radial artery harvesting, valve replacements, minimally invasive aortic and mitral valve repair/replacements, ascending aorta/aortic dissection/aortic arch repair/replacements, redo surgeries, coronary artery bypass grafting (off and on-pump), robotic-assisted minimally invasive coronary artery bypass grafting, minimally invasive myocardial bridge unroofing, heart/lung transplants, VADs, and ECMO.
Beyond her clinical duties, Mary plays a crucial role in training new PAs, NPs, APP fellows, residents, and medical students in various surgical skills. In the clinic, she performs history & physicals, pre-op evaluations, orders/interprets studies & labs, and coordinates in-patient and out-patient care.
Since January 2015, Mary has been the driving force behind the Stanford Department of Cardiothoracic Surgery's Human Biorepository Tissue Bank. This initiative has amassed over 1,000 human cardiothoracic tissue samples, fostering approved studies to advance cardiovascular and pulmonary disease research. Collaborating with over 30 partners and Stanford labs, Mary's goal is to facilitate research by providing cardiothoracic tissue samples to researchers and scientists across Stanford Medicine.
Currently, Mary holds the position of Principal Academic and Clinical Integration Developer in the CT Surgery Department, further highlighting her leadership role in our institution. In this capacity, she plays a pivotal role in curating and developing marketing materials and outreach strategies for the department. Mary's dedication extends beyond clinical excellence; she actively contributes to fostering academic growth and enhancing the department's visibility. Her strategic approach to marketing ensures that the department's achievements and advancements in cardiothoracic surgery are effectively communicated to the broader medical community and the public, reinforcing our commitment to excellence in patient care, research, and education.
Furthermore, Mary has been an esteemed member of Dr. Joseph Woo's Stanford Advanced Cardiovascular Therapeutics and Surgical Biomechanics Translational Research Laboratory (Woo Lab) since 2012. Her involvement in numerous clinical trials and published research underscores her commitment to advancing the field of cardiovascular medicine. Learn more about Woo Lab at http://med.stanford.edu/woolab.html. -
Rebecca Bilden
Postdoctoral Scholar, Psychiatry
BioRebecca Bilden, PhD, MSc is a T32 Postdoctoral Fellow in Pain and Substance Use at Stanford University School of Medicine, where she conducts research under the mentorship of Drs. Keith Humphreys and Brian Bateman. Dr. Bilden is a health services researcher and decision scientist whose work focuses on improving access to treatment for substance use disorders through evidence-based policy and simulation modeling. By integrating qualitative insights into models, she analyzes system dynamics and develops strategies to improve care delivery within complex healthcare systems.
Dr. Bilden earned her PhD in Health Services Research and Policy from the University of Pittsburgh, an MSc in Applied Data Science and Statistics from the University of Exeter, and a BA in Pure and Applied Mathematics from Boston University. Her current research focuses on evaluating opioid-related policies, improving treatment retention among pregnant people, and expanding access to care in carceral settings.
